Esperion Therapeutics, Inc. earnings per share and revenue

ESPR earnings per share for the last quarter are -0.11 USD whereas the estimation was -0.15 USD which accounts for 25.96% surprise. Company revenue for the same period amounts to 69.11 M USD despite the estimated figure of 61.58 M USD. Estimated earnings per share for the next quarter are -0.16 USD, and revenue is expected to reach 53.03 M USD. Also watch annual changes over time to get a bigger picture of ESPR earnings per share and revenue dynamics.